ArticleHeliyon2024
Explaining the causes and motivations for multiple substance use from the perspectives of users and therapists: A qualitative study.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The high prevalence of multiple substance use (MSU) is concerning, given the weak awareness about this issue and the potential impact this unawareness has on the severity of substance use disorder (SUD) and treatment outcomes. The aim of this study is to identify and elucidate the causes and motivations for MSU from the viewpoints of users and therapists in this field. Methods: In this qualitative study, the conventional content analysis approach and purposive sampling were utilized. Deep semi-structured exploratory interviews were conducted with 17 substance users and 8 addiction therapists (including 4 psychiatrists, 3 general practitioners, and 1 psychologist). Field notes were also taken to identify and explain the motivations and reasons for MSU from the perspectives of users and therapists. The data were analyzed comparatively and simultaneously using the method suggested by Graneheim and Lundman (2004). Results: Based on the findings of this study, the motivations for MSU are reflected in four main categories: 'Pharmacological factors' with subcategories such as achieving desired states and mitigating the undesirable effects of substances through leveraging the balancing, synergistic, and antagonistic effects of substances, substituting the effects of other substances, self-medication of the undesirable effects of other substances, enhancing the overall consumption experience such as heightened peak experience and enhanced pleasure, moderating the come-down, and seeking euphoria experiences in different substances; 'Biological factors' with subcategories including different neurobehavioral systems, individual differences determining substance dependence and the somatic-neural vulnerability of consumers; 'Psychosocial factors' with the subcategories of undesirable norms like the need for acceptance and social interactions, the context of substance use, consumers' experiences and expectations of substance use, and the maladaptive personality traits of consumers; and 'Addiction's inevitability' with the subcategories of coercion and the need to maintain equilibrium, and the difficulties of substance detoxification. Conclusion: The motivations behind Multiple Substance Use (MSU) behaviors are multifaceted, including pharmacological, biological, psychosocial, and addiction-related factors. Recognizing and comprehending the interplay between these factors and motivations can inform better prevention strategies, assessment of treatment needs, and enhancement of treatment outcomes for individuals dealing with MSU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.